Ontology highlight
ABSTRACT:
SUBMITTER: Sckisel GD
PROVIDER: S-EPMC4782757 | biostudies-literature | 2015 Dec
REPOSITORIES: biostudies-literature
Sckisel Gail D GD Mirsoian Annie A Bouchlaka Myriam N MN Tietze Julia K JK Chen Mingyi M Blazar Bruce R BR Murphy William J WJ
Cancer immunology, immunotherapy : CII 20150930 12
We have demonstrated that immunostimulatory therapies such as interleukin-2 (IL-2) and anti-CD40 (αCD40) can be combined to deliver synergistic anti-tumor effects. While this strategy has shown success, efficacy varies depending on a number of factors including tumor type and severe toxicities can be seen. We sought to determine whether blockade of negative regulators such as cytotoxic T lymphocyte antigen-4 (CTLA-4) could simultaneously prolong CD8(+) T cell responses and augment T cell anti-tu ...[more]